Maryland Medicaid and semaglutide
Wegovy for weight loss: no. Prior authorization for established heart disease with overweight or obesity (BMI 27 or higher), or for a liver condition (MASH) with moderate to advanced fibrosis. Ozempic for weight loss: no; for type 2 diabetes Maryland Medicaid must cover it. Read from Maryland Department of Health, Office of Pharmacy Services documents Nov 6, 2026.
Wegovy · Maryland Department of Health, Medical Benefits Management
“Wegovy will not be covered when the sole indication is for chronic weight management”
read Nov 6, 2026
Wegovy · Maryland Department of Health, Office of Pharmacy Services
“Patient has non-cirrhotic metabolic dysfunction-associated steatohepatitis (MASH)”
read Nov 6, 2026
In 2025 Maryland Medicaid paid for 109,871 semaglutide prescriptions (Ozempic, Rybelsus, Wegovy), 74% of its GLP-1 prescriptions and 9th of the 50 states and DC. It reimbursed $105.2 million before rebates, $958 a prescription against $1,104 nationally.
| Brand | Prescriptions | Medicaid paid | Per Rx |
|---|---|---|---|
| Ozempic | 101,266 | $96.6 million | $954 |
| Rybelsus | 7,465 | $7.1 million | $954 |
| Wegovy | 1,140 | $1.5 million | $1,275 |
Semaglutide in the states around Maryland
| State | Sell semaglutide, ship there | Cheapest | Medicaid Rx, 2025 | Medicaid, Wegovy for weight loss |
|---|---|---|---|---|
| Maryland | 19 | $39/moWellmedr | 109,871 | Medicaid Wegovy: No |
| Delaware | 19 | $39/moWellmedr | 36,313 | Medicaid Wegovy: Unclear |
| Pennsylvania | 19 | $39/moWellmedr | 485,068 | Medicaid Wegovy: No |
| Virginia | 19 | $39/moWellmedr | 55,560 | Medicaid Wegovy: Yes |
| West Virginia | 18 | $39/moWellmedr | 75,835 | Medicaid Wegovy: No |
| Washington, DC | not ranked | none verified | 16,469 | Medicaid Wegovy: No |



